Latest update on Coronavirus vaccine: After Pfizer, the Serum Institute of India has sought emergency authorization for COVID-19 vaccine ‘Covishield’ from the Drugs Controller General of India. By doing this, Serum Institute has become the first indigenous company to apply for authorization to the DCGI.
The Pune-based Serum Institute of India is conducting the phase-three clinical trial of the Oxford COVID-19 vaccine, ‘Covishield’. The Indian arm of US pharmaceutical giant Pfizer became the first to seek a similar approval from India's drug regulator for its own COVID-19 vaccine in the country. This news comes in amid the surging crises of COVID-19 pandemic, especially in the National Capital.
SUBSCRIBE NOW for more such videos ►[ Ссылка ]
For More Updates ► [ Ссылка ]
Like us on Facebook ► [ Ссылка ]
Follow us on Twitter ► [ Ссылка ]
Follow us on Instagram ► [ Ссылка ]
